skip to main content
Main Site Navigation
Top of main content

Clinical Trials Details

A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) plus Memantine for 5 or more Brain Metastases

Location: Carle Cancer Institute - Urbana - IL168
Body site or condition: Brain Metastases
Department: Cancer Research

Alliance CCTG-CE7

Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. --Whole brain radiation therapy (WBRT) is when radiation therapy is given to the whole brain. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. --Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.

Apply Now